Dermatopharmacology: drugs around the corner.
This article describes impending advances in drug treatment of skin diseases. We have included the following categories: (1) interesting new drugs for which there are reasonable prospects of eventual licensing for skin indications, (2) important novel compounds whose progress through licensing procedures, although incomplete at the time of writing, is advanced, and (3) new indications or improved regimens that have recently emerged for established drugs.
Greaves
M W
MW
Institute of Dermatology, University of London, St Thomas' Hospital.
Dowd
P M
PM
Hawk
J L
JL
D001379:Azathioprine / Q000627:therapeutic use; D003534:Cyproterone / Q000031:analogs & derivatives / Q000627:therapeutic use; D017373:Cyproterone Acetate; D011564:Furocoumarins / Q000627:therapeutic use; D007987:Gonadotropin-Releasing Hormone / Q000627:therapeutic use; D006801:Humans; D009543:Nifedipine / Q000627:therapeutic use; D012871:Skin Diseases / Q000188:drug therapy*
D011564:Furocoumarins; D007987:Gonadotropin-Releasing Hormone; D017373:Cyproterone Acetate; D003534:Cyproterone; D009543:Nifedipine; D001379:Azathioprine